FOLH1 and posterior cortical atrophy: Radiographic assessment at the stage of biochemically recurrent (BCR) PCa disease has been transformed by the advent of prostate-specific membrane antigen (PSMA) targeting radioligands, with recent years seeing the development of numerous ligands that bind with the PSMA transmembrane protein to facilitate either diagnostic or therapeutic applications5–7.